Autres langues 10x Genomics, Inc.

Actions

TXG

US88025U1097

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 08/05/2024			Varia. 5j.	Varia. 1 janv.
25,36 ^USD	-2,98 %		-5,79 %	-54,68 %

07/05	NanoString de Bruker obtient gain de cause dans une affaire de brevet en Allemagne	MT
01/05	10X GENOMICS, INC. : UBS conserve son opinion neutre	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Bruker's NanoString Secures Patent Case Win in Germany	07/05
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference	02/05
Olden Labs Launches The World's First Automated Animal Research Lab	02/05
North American Morning Briefing : Stock Futures -2-	02/05
10x Genomics : First Quarter 2024 Prepared Remarks	01/05
Earnings Flash (TXG) 10X GENOMICS Reports Q1 Revenue $141M, vs. Street Est of $142.1M	30/04
10x Genomics: Q1 Earnings Snapshot	30/04
10x Genomics Reports First Quarter 2024 Financial Results	30/04
10x Genomics, Inc. Reaffirms Revenue Guidance for the Year 2024	30/04
10x Genomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
Petition Denied For Lacking Section 112(f) Construction And Fintiv	18/04
The UPC Court Of Appeal's First Decision: What Does It Mean For The Assessment Of Inventive Step At The UPC?	17/04
UPC Court Of Appeal Overturns Preliminary Injunction In Its First Substantive Decision	15/04
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024	10/04
UPC Court Of Appeal Reverses Preliminary Injunction In First Substantive Decision	29/03
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay	26/03
10x Genomics, Inc. Commercially Launches Visium HD Spatial Gene Expression Assay	26/03
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel	21/03
10X Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel	21/03
Vizgen Announces Denial of 10x Genomics Petition for Inter Partes Review of Vizgen-Licensed Patent Currently Asserted against 10x's Xenium Platform	14/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues 10x Genomics, Inc.

Actions

TXG

US88025U1097

Autres langues

Filtres